Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Clinical trial NCT03269994 · COMPLETED

Trial details

NCT number: NCT03269994
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer Pancreas Cancer Pancreatic Diseases

Start date: 2017-11-21
Primary completion: 2025-01-28
Enrollment: 967

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.